| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 32 |
| 1 | ALBUTEROL SULFATE | 24 |
| 2 | ASPIRIN | 22 |
| 3 | FUROSEMIDE | 22 |
| 4 | ASPIRIN 325 MG | 21 |
| 5 | ASPIRIN 81 MG | 21 |
| 6 | INSULIN GLARGINE | 19 |
| 7 | OMALIZUMAB | 19 |
| 8 | TIOTROPIUM BROMIDE | 19 |
| 9 | CICLESONIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 17 | 0.0020 |
| 1 | SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE | 1 | 0.0013 |
| 2 | CICLESONIDE | 18 | 0.0013 |
| 3 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 4 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| 5 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 7 | ESTROGEN | 2 | 0.0007 |
| 8 | LEVOMILNACIPRAN HYDROCHLORIDE | 1 | 0.0005 |
| 9 | PITOLISANT HYDROCHLORIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Dihydropyridine Calcium Channel Blocker [EPC] | 34 |
| 1 | Calcium Channel Blocker [EPC] | 32 |
| 2 | Corticosteroid [EPC] | 29 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 4 | Loop Diuretic [EPC] | 22 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 6 | Insulin Analog [EPC] | 21 |
| 7 | Anti-IgE [EPC] | 19 |
| 8 | Glycopeptide Antibacterial [EPC] | 17 |
| 9 | beta-Adrenergic Blocker [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 1 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 2 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Glycopeptide Antibacterial [EPC] | 17 | 0.0003 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Anti-IgE [EPC] | 19 | 0.0002 |
| 6 | Calcitonin Gene-related Peptide Antagonist [EPC] | 2 | 0.0002 |
| 7 | Androgen [EPC] | 5 | 0.0002 |
| 8 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |